COM:MERSANA
Mersana Therapeutics
- Stock
Last Close
2.22
21/11 21:00
Market Cap
239.83M
Beta: -
Volume Today
1.01M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.72 - | 0.24 66.68% | 0.13 43.96% | 0.13 0.54% | 0.39 190.25% | 0.00 99.23% | 0.00 93.11% | 0.08 38,007.96% | 0.16 105.06% | |
cash conversion cycle | -1.76K - | |||||||||
cash per share | 0.66 - | 5.73 769.58% | 9.54 66.44% | 3.04 68.09% | 2.29 24.65% | 4.15 80.82% | 2.52 39.23% | 4.62 83.19% | 1.80 61.01% | |
company equity multiplier | -0.34 - | -1.89 459.81% | 1.87 198.84% | 8.93 377.95% | 1.37 84.62% | 1.20 12.71% | 1.69 41.24% | 3.63 114.52% | 6.13 68.66% | |
days of inventory outstanding | ||||||||||
days of payables outstanding | 1.76K - | |||||||||
days of sales outstanding | 22.55 - | 15.24 32.42% | 16.31 7.02% | 15.81 3.04% | 411.95 - | |||||
dividend yield | 0.00 - | 0.00 82.53% | 0.00 325.16% | 0.35 - | ||||||
ebit per revenue | -1.58 - | -0.55 65.19% | -2.26 311.23% | -6.20 174.46% | -0.69 88.81% | -105.90 15,167.01% | -3.95K 3,626.89% | -7.70 99.80% | -4.64 39.76% | |
ebt per ebit | 1.01 - | 0.99 1.40% | 0.98 1.43% | 0.98 0.17% | 0.97 1.36% | 1.00 4.01% | 1.00 0.20% | 1.00 0.44% | 1.00 0.65% | |
effective tax rate | 0.00 - | -0.02 - | 0.04 264.74% | -0.00 111.38% | 0.01 223.30% | -0.02 424.14% | ||||
enterprise value multiple | -14.55 - | -10.98 24.49% | -4.42 59.77% | -0.52 88.16% | -6.96 1,230.26% | -16.12 131.76% | -1.77 89.01% | -1.49 15.70% | -0.76 49.17% | |
fixed asset turnover | 8.07 - | 10.14 25.65% | 7.57 25.37% | 3.93 48.02% | 8.85 124.94% | 0.07 99.26% | 0.00 95.57% | 1.84 63,413.45% | 3.20 73.96% | |
free cash flow per share | -0.59 - | 1.74 397.45% | -3.64 309.03% | -2.46 32.60% | -1.57 36.03% | -1.22 22.21% | -1.99 62.98% | -0.55 72.37% | -1.47 167.58% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.96 4.12% | |
interest coverage | -124.87 - | -244.25 95.61% | -133.95 45.16% | -61.51 54.08% | -41.97 31.76% | |||||
inventory turnover | ||||||||||
long term debt to capitalization | 0.06 - | 0.06 6.13% | 0.23 265.76% | 0.27 17.24% | 0.39 44.46% | |||||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 0.96 3.58% | 1.00 4.14% | 0.99 0.91% | 1.02 2.14% | 1 1.60% | |
net profit margin | -1.59 - | -0.54 65.68% | -2.21 305.34% | -6.07 174.93% | -0.65 89.36% | -106.77 16,436.36% | -3.94K 3,585.56% | -7.81 99.80% | -4.66 40.34% | |
operating cash flow per share | -0.55 - | 1.81 427.81% | -3.55 296.59% | -2.40 32.47% | -1.56 35.03% | -1.21 22.01% | -1.98 63.26% | -0.53 73.43% | -1.45 175.95% | |
operating cycle | ||||||||||
operating profit margin | -1.58 - | -0.55 65.19% | -2.26 311.23% | -6.20 174.46% | -0.69 88.81% | -105.90 15,167.01% | -3.95K 3,626.89% | -7.70 99.80% | -4.64 39.76% | |
payables turnover | 0.21 - | |||||||||
pretax profit margin | -1.59 - | -0.54 65.68% | -2.21 305.34% | -6.07 174.93% | -0.67 88.96% | -106.33 15,778.93% | -3.95K 3,619.28% | -7.68 99.81% | -4.66 39.37% | |
price fair value | -5.74 - | -4.40 23.24% | 2.82 164.09% | 10.68 278.60% | 3.18 70.22% | 7.17 125.43% | 3.61 49.73% | 5.96 65.32% | 7.30 22.44% | |
receivables turnover | 16.19 - | 23.95 47.97% | 22.38 6.56% | 23.08 3.14% | 0.89 - | |||||
return on assets | -1.14 - | -0.13 88.57% | -0.30 127.14% | -0.82 176.42% | -0.25 69.10% | -0.32 27.86% | -0.82 153.88% | -0.62 24.39% | -0.76 22.34% | |
return on capital employed | -4.45 - | -0.18 95.95% | -0.40 122.45% | -7.23 1,704.47% | -0.35 95.16% | -0.36 2.92% | -1.07 197.05% | -0.84 21.22% | -1.05 24.85% | |
return on equity | 0.38 - | 0.25 35.99% | -0.55 324.51% | -7.31 1,221.16% | -0.35 95.25% | -0.39 11.61% | -1.39 258.60% | -2.25 62.21% | -4.65 106.34% | |
total debt to capitalization | 0.09 - | 0.07 24.90% | 0.24 252.44% | 0.28 18.47% | 0.44 54.46% |
All numbers in (except ratios and percentages)